These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28740522)

  • 1. Use of teriparatide off-label: our experience and review of literature.
    Ciurlia E; Leali PT; Doria C
    Clin Cases Miner Bone Metab; 2017; 14(1):28-34. PubMed ID: 28740522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Teriparatide to improve fracture healing: What is the evidence?
    Babu S; Sandiford NA; Vrahas M
    World J Orthop; 2015 Jul; 6(6):457-61. PubMed ID: 26191492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis.
    Eriksen EF; Keaveny TM; Gallagher ER; Krege JH
    Bone; 2014 Oct; 67():246-56. PubMed ID: 25053463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4. The Low-Intensity Pulsed Ultrasound (LIPUS) Mechanism and the Effect of Teriparatide on Fracture Healing.
    Naruse K; Uchino M; Hirakawa N; Toyama M; Miyajima G; Mukai M; Urabe K; Uchida K; Itoman M
    J Orthop Trauma; 2016 Aug; 30(8):S3. PubMed ID: 27441765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriparatide may accelerate healing in delayed unions of type III odontoid fractures: a report of 3 cases.
    Rubery PT; Bukata SV
    J Spinal Disord Tech; 2010 Apr; 23(2):151-5. PubMed ID: 20051918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT; Christensen PM; Ejersted C; Langdahl BL
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teriparatide in Fracture Non-Unions.
    Coppola C; Del Buono A; Maffulli N
    Transl Med UniSa; 2015; 12():47-53. PubMed ID: 26535187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
    Ebeling PR; Russell RG
    Int J Clin Pract; 2003 Oct; 57(8):710-8. PubMed ID: 14627183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anabolic agents: what is beyond osteoporosis?
    Liu Y; Levack AE; Marty E; Or O; Samuels BP; Redko M; Lane JM
    Osteoporos Int; 2018 May; 29(5):1009-1022. PubMed ID: 29627891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of teriparatide in osteoporotic fracture patients.
    Collinge C; Favela J
    Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
    Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
    BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teriparatide therapy for denosumab-induced osteonecrosis of the jaw in a male osteoporotic patient.
    Neuprez A; Rompen E; Crielaard JM; Reginster JY
    Calcif Tissue Int; 2014 Jul; 95(1):94-6. PubMed ID: 24804929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery.
    Ohtori S; Orita S; Yamauchi K; Eguchi Y; Ochiai N; Kuniyoshi K; Aoki Y; Nakamura J; Miyagi M; Suzuki M; Kubota G; Inage K; Sainoh T; Sato J; Shiga Y; Abe K; Fujimoto K; Kanamoto H; Inoue G; Takahashi K
    Asian Spine J; 2015 Aug; 9(4):573-80. PubMed ID: 26240717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with recombinant parathyroid hormone of advanced osteoporosis--series of cases].
    Skiba K; Adamczak M; Wiecek A
    Przegl Lek; 2011; 68(7):391-5. PubMed ID: 22010479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Osteoporosis Therapies in Combination.
    McClung MR
    Curr Osteoporos Rep; 2017 Aug; 15(4):343-352. PubMed ID: 28667435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk.
    Sugimoto T; Shiraki M; Fukunaga M; Hagino H; Sone T; Nakano T; Kishimoto H; Ito M; Yoshikawa H; Kishida M; Irie C; Nakamura T
    Adv Ther; 2017 Jul; 34(7):1727-1740. PubMed ID: 28631217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly teriparatide administration for the treatment of delayed union: a report of two cases.
    Tachiiri H; Okuda Y; Yamasaki T; Kusakabe T
    Arch Osteoporos; 2014; 9():179. PubMed ID: 24777526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peri-prosthetic humeral non-union: Where biology meets bio-mechanic. A case report.
    Emanuele C; Leonardo P; Gianfilippo C; Matteo A; Doria C
    Int J Surg Case Rep; 2017; 39():102-105. PubMed ID: 28826070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study.
    Ohtori S; Inoue G; Orita S; Yamauchi K; Eguchi Y; Ochiai N; Kishida S; Kuniyoshi K; Aoki Y; Nakamura J; Ishikawa T; Miyagi M; Kamoda H; Suzuki M; Kubota G; Sakuma Y; Oikawa Y; Inage K; Sainoh T; Takaso M; Ozawa T; Takahashi K; Toyone T
    Spine (Phila Pa 1976); 2012 Nov; 37(23):E1464-8. PubMed ID: 22872218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
    Hodsman AB; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; Kendler DL; McClung MR; Miller PD; Olszynski WP; Orwoll E; Yuen CK
    Endocr Rev; 2005 Aug; 26(5):688-703. PubMed ID: 15769903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.